Blood test tracks diabetes risk in cystic fibrosis patients
NCT ID NCT03713437
First seen Apr 16, 2026 · Last updated May 09, 2026 · Updated 6 times
Summary
This study looked at whether a blood test can measure the death of insulin-making cells in people with cystic fibrosis. Researchers compared levels of a specific DNA marker in 40 participants with cystic fibrosis and healthy controls. The goal was to understand how beta cell death relates to the development of diabetes in cystic fibrosis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS RELATED DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital and Medical Center
Omaha, Nebraska, 68114, United States
Conditions
Explore the condition pages connected to this study.